OneSource Specialty Pharma Limited (BOM:544292)
1,850.55
-2.30 (-0.12%)
At close: Oct 30, 2025
BOM:544292 Statistics
Total Valuation
BOM:544292 has a market cap or net worth of INR 215.06 billion. The enterprise value is 221.38 billion.
| Market Cap | 215.06B |
| Enterprise Value | 221.38B |
Important Dates
The next estimated earnings date is Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 114.53M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +155.88% |
| Shares Change (QoQ) | -18.90% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 25.81% |
| Float | 68.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 43.61 |
| PS Ratio | 14.53 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 42.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1,755.61 |
| EV / Sales | 14.96 |
| EV / EBITDA | 40.95 |
| EV / EBIT | 101.84 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.74 |
| Debt / FCF | n/a |
| Interest Coverage | 1.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.48M |
| Profits Per Employee | -89,306 |
| Employee Count | 1,412 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -129.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1,843.02 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 57.33 |
| Average Volume (20 Days) | 3,721 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544292 had revenue of INR 14.80 billion and -126.10 million in losses. Loss per share was -1.19.
| Revenue | 14.80B |
| Gross Profit | 10.51B |
| Operating Income | 2.17B |
| Pretax Income | -248.49M |
| Net Income | -126.10M |
| EBITDA | 5.41B |
| EBIT | 2.17B |
| Loss Per Share | -1.19 |
Balance Sheet
The company has 3.10 billion in cash and 9.42 billion in debt, giving a net cash position of -6.33 billion.
| Cash & Cash Equivalents | 3.10B |
| Total Debt | 9.42B |
| Net Cash | -6.33B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 58.81B |
| Book Value Per Share | 514.02 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.99%, with operating and profit margins of 14.69% and -0.85%.
| Gross Margin | 70.99% |
| Operating Margin | 14.69% |
| Pretax Margin | -1.68% |
| Profit Margin | -0.85% |
| EBITDA Margin | 36.53% |
| EBIT Margin | 14.69% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544292 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -155.88% |
| Shareholder Yield | -155.88% |
| Earnings Yield | -0.06% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |